Gyre Therapeutics(DE:L9S)
€4.12+-0.14 (+17.05%)
DE:L9S
Gyre Therapeutics Revenue
€4.12
At close:+-0.14 (+17.05%)
Gyre Therapeutics (L9S) Revenue
1 Followers
Gyre Therapeutics Revenue
Gyre Therapeutics had a revenue of 32.93M in the quarter ending Sep 30, 2026, with 13.16%. This bring the company's revenue in the last twelve months to 121.75M, Increased 1.99%. In the fiscal year ending Dec 31, 2025, Gyre Therapeutics had annual revenue of 116.59M with 10.24% growth.
- Revenue (ttm)
- 121.75M
- Revenue Growth
- 8.26%
- P/S Ratio
- 3.77
- Revenue/Employee
- EUR 186,541
- Employees
- 625
- Market Cap
- EUR 439.60M
Revenue Chart
Gyre Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.59M | 10.83M | 10.24% |
| Dec 31, 2024 | 105.76M | -7.69M | -6.78% |
| Dec 31, 2023 | 113.45M | 11.16M | 10.91% |
| Dec 31, 2022 | 102.29M | 94.95M | 1293.98% |
| Mar 31, 2022 | 7.34M | -13.61M | -64.97% |
| Dec 31, 2020 | 20.95M | 20.95M | ― |
| Dec 31, 2019 | 0.00 | -6.00K | -100.00% |
| Dec 31, 2018 | 6.00K | -1.01M | -99.41% |
| Dec 31, 2017 | 1.02M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.